These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14676301)

  • 1. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor.
    Yeh S; Hu YC; Wang PH; Xie C; Xu Q; Tsai MY; Dong Z; Wang RS; Lee TH; Chang C
    J Exp Med; 2003 Dec; 198(12):1899-908. PubMed ID: 14676301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice.
    Li H; Rajendran GK; Liu N; Ware C; Rubin BP; Gu Y
    Breast Cancer Res; 2007; 9(1):R1. PubMed ID: 17201918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor inactivation resulted in acceleration in pubertal mammary gland growth, upregulation of ERα expression, and Wnt/β-catenin signaling in female mice.
    Gao YR; Walters KA; Desai R; Zhou H; Handelsman DJ; Simanainen U
    Endocrinology; 2014 Dec; 155(12):4951-63. PubMed ID: 25076121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
    Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A
    J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland.
    Peters AA; Ingman WV; Tilley WD; Butler LM
    Endocrinology; 2011 Oct; 152(10):3728-37. PubMed ID: 21846805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development.
    Grimm SL; Seagroves TN; Kabotyanski EB; Hovey RC; Vonderhaar BK; Lydon JP; Miyoshi K; Hennighausen L; Ormandy CJ; Lee AV; Stull MA; Wood TL; Rosen JM
    Mol Endocrinol; 2002 Dec; 16(12):2675-91. PubMed ID: 12456789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions.
    Richert MM; Wood TL
    Endocrinology; 1999 Jan; 140(1):454-61. PubMed ID: 9886857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.
    Ruan W; Kleinberg DL
    Endocrinology; 1999 Nov; 140(11):5075-81. PubMed ID: 10537134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.
    Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J
    Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Alx4, a stromally-restricted homeodomain protein, impairs mammary epithelial morphogenesis.
    Joshi PA; Chang H; Hamel PA
    Dev Biol; 2006 Sep; 297(1):284-94. PubMed ID: 16916507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer.
    Wu X; Chen F; Sahin A; Albarracin C; Pei Z; Zou X; Singh B; Xu R; Daniels G; Li Y; Wei J; Blake M; Schneider RJ; Cowin P; Lee P
    Breast Cancer Res Treat; 2011 Jul; 128(2):391-400. PubMed ID: 20814820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
    Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth.
    Zeps N; Bentel JM; Papadimitriou JM; D'Antuono MF; Dawkins HJ
    Differentiation; 1998 Mar; 62(5):221-6. PubMed ID: 9566307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland.
    Jäger R; Schäfer S; Hau-Liersch M; Schorle H
    Dev Dyn; 2010 Mar; 239(3):1027-33. PubMed ID: 20131354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I.
    Richards RG; Klotz DM; Walker MP; Diaugustine RP
    Endocrinology; 2004 Jul; 145(7):3106-10. PubMed ID: 15059953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.